Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08UZP
|
|||
| Former ID |
DIB011524
|
|||
| Drug Name |
MPL-containing Pollinex allergy desensitization vaccine
|
|||
| Synonyms |
Grass MATA MPL; MATA-MPL; MPL-containing Pollinex allergy desensitization injectable vaccine (grass); Grass SC vaccine (injectable), Allergy Therapeutics/AllerPharma; Pollinex Quattro (injectable grass allergy vaccine), Allergy Therapeutics/AllerPharma; Quattro MPL (injectable grass allergy vaccine), Allergy Therapeutics/AllerPharma; MPL-containing Pollinex allergy desensitization injectable vaccine (grass), Allergy Therapeutics/AllerPharma
Click to Show/Hide
|
|||
| Indication | Angina pectoris [ICD-11: BA40; ICD-9: 413] | Phase 3 | [1] | |
| Allergy [ICD-11: 4A80-4A85; ICD-10: T78.4; ICD-9: 995.3] | Phase 2 | [2] | ||
| Company |
Allergy therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00423787) Efficacy and Safety/Tolerability of Ragweed MATA MPL. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Allergy Therapeutics plc. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.